Massive Bio is building the world's largest global real time cancer registry with patient consented clinical and genomic data.
Massive Bio has raised $16.5M in total funding. The most recent round was Series A. The last funding was announced in June 2022.
Massive Bio's investors include 500 Global, Revo Capital, KFW DEG, SiteGround, ImpactAssets.
Massive Bio is headquartered in Boca Raton, United States.
Massive Bio is building the world's largest global real time cancer registry with patient consented clinical and genomic data.
Massive Bio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Massive Bio — Funding & Investors." VCBacked, June 2, 2022, https://www.vcbacked.co/company/massive-bio. Accessed November 13, 2026.
VCBacked. (2022). Massive Bio — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/massive-bio
{{cite web |title=Massive Bio — Funding & Investors |url=https://www.vcbacked.co/company/massive-bio |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Massive Bio? Request a listing update